Filing Details
- Accession Number:
- 0001181431-12-006043
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-06 13:23:36
- Reporting Period:
- 2012-02-02
- Filing Date:
- 2012-02-06
- Accepted Time:
- 2012-02-06 13:23:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356857 | Trius Therapeutics Inc | TSRX | Pharmaceutical Preparations (2834) | 201320630 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1478916 | P. John Schmid | C/O Trius Therapeutics, Inc. 6310 Nancy Ridge Drive, Suite 101 San Diego CA 92121 | Cfo And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-02-02 | 500 | $5.63 | 104,939 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2011.
Billionaire Hedge Funds
